{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:29:13Z","timestamp":1759742953972},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"DOI":"10.7759\/cureus.65955","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T16:21:14Z","timestamp":1722529274000},"source":"Crossref","is-referenced-by-count":1,"title":["Clinical and Microbiological Profile of Gram-Negative Infections in Critically Ill Diabetic Patients"],"prefix":"10.7759","author":[{"given":"Bhumika","family":"Vaishnav","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniruddh","family":"Wadivkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruchitha","family":"Pailla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saish","family":"Mondkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2012.02.026","article-title":"Sepsis in diabetes: a bad duo","volume":"5","author":"Tiwari S","year":"2011","unstructured":"Tiwari S, Pratyush DD, Gahlot A, Singh SK. Sepsis in diabetes: a bad duo. Diabetes Metab Syndr. 2011, 5:222-7. 10.1016\/j.dsx.2012.02.026","journal-title":"Diabetes Metab Syndr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee M","year":"2001","unstructured":"Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001, 414:813-20. 10.1038\/414813a","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.2.553","article-title":"Management of diabetes and hyperglycemia in hospitals","volume":"27","author":"Clement S","year":"2004","unstructured":"Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, Hirsch IB. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004, 27:553-91. 10.2337\/diacare.27.2.553","journal-title":"Diabetes Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1086\/431587","article-title":"Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus","volume":"41","author":"Muller LM","year":"2005","unstructured":"Muller LM, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, Hoepelman AI, Rutten GE. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis. 2005, 41:281-8. 10.1086\/431587","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ21-0690","article-title":"Association between the duration of diabetes and gram-negative bacterial infection in diabetic foot infections: a case-control study","volume":"69","author":"Chen S","year":"2022","unstructured":"Chen S, Tan X, Li X, Zhao T. Association between the duration of diabetes and gram-negative bacterial infection in diabetic foot infections: a case-control study. Endocr J. 2022, 69:1061-5. 10.1507\/endocrj.EJ21-0690","journal-title":"Endocr J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.13836","article-title":"Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014","volume":"318","author":"Rhee C","year":"2017","unstructured":"Rhee C, Dantes R, Epstein L, et al.. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014. JAMA. 2017, 318:1241-9. 10.1001\/jama.2017.13836","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2019.00054","article-title":"Stress hyperglycemia in critically ill patients: insight into possible molecular pathways","volume":"6","author":"Bar-Or D","year":"2019","unstructured":"Bar-Or D, Rael LT, Madayag RM, et al.. Stress hyperglycemia in critically ill patients: insight into possible molecular pathways. Front Med (Lausanne). 2019, 6:54. 10.3389\/fmed.2019.00054","journal-title":"Front Med (Lausanne)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04750-w","article-title":"Prognostic differences in sepsis caused by gram-negative bacteria and gram-positive bacteria: a systematic review and meta-analysis","volume":"27","author":"Tang A","year":"2023","unstructured":"Tang A, Shi Y, Dong Q, et al.. Prognostic differences in sepsis caused by gram-negative bacteria and gram-positive bacteria: a systematic review and meta-analysis. Crit Care. 2023, 27:467. 10.1186\/s13054-023-04750-w","journal-title":"Crit Care"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.3.8341","article-title":"Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes","volume":"87","author":"Umpierrez GE","year":"2002","unstructured":"Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002, 87:978-82. 10.1210\/jcem.87.3.8341","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-29978-y","article-title":"Socioeconomic inequality in awareness, treatment and control of diabetes among adults in India: Evidence from National Family Health Survey of India (NFHS), 2019-2021","volume":"13","author":"Maiti S","year":"2023","unstructured":"Maiti S, Akhtar S, Upadhyay AK, Mohanty SK. Socioeconomic inequality in awareness, treatment and control of diabetes among adults in India: Evidence from National Family Health Survey of India (NFHS), 2019-2021. Sci Rep. 2023, 13:2971. 10.1038\/s41598-023-29978-y","journal-title":"Sci Rep"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.39346.495880.AE","article-title":"Sepsis: definition, epidemiology, and diagnosis","volume":"335","author":"Lever A","year":"2007","unstructured":"Lever A, Mackenzie I. Sepsis: definition, epidemiology, and diagnosis. BMJ. 2007, 335:879-83.","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.36","article-title":"The immunopathology of sepsis and potential therapeutic targets","volume":"17","author":"van der Poll T","year":"2017","unstructured":"van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017, 17:407-20. 10.1038\/nri.2017.36","journal-title":"Nat Rev Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(15)00379-4","article-title":"Diabetes and infection: assessing the association with glycaemic control in population-based studies","volume":"4","author":"Pearson-Stuttard J","year":"2016","unstructured":"Pearson-Stuttard J, Blundell S, Harris T, Cook DG, Critchley J. Diabetes and infection: assessing the association with glycaemic control in population-based studies. Lancet Diabetes Endocrinol. 2016, 4:148-58. 10.1016\/S2213-8587(15)00379-4","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in critically ill patients","volume":"345","author":"van den Berghe G","year":"2001","unstructured":"van den Berghe G, Wouters P, Weekers F, et al.. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001, 345:1359-67. 10.1056\/NEJMoa011300","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.2.510","article-title":"Quantifying the risk of infectious diseases for people with diabetes","volume":"26","author":"Shah BR","year":"2003","unstructured":"Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003, 26:510-3. 10.2337\/diacare.26.2.510","journal-title":"Diabetes Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-019-0810-8","article-title":"Improved outcome of patients with diabetes mellitus with good glycemic control in the cardiac intensive care unit: a retrospective study","volume":"18","author":"Sharif K","year":"2019","unstructured":"Sharif K, Ghadir S, Jakubowicz D, et al.. Improved outcome of patients with diabetes mellitus with good glycemic control in the cardiac intensive care unit: a retrospective study. Cardiovasc Diabetol. 2019, 18:4. 10.1186\/s12933-019-0810-8","journal-title":"Cardiovasc Diabetol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.2691","article-title":"Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis","volume":"315","author":"van Vught LA","year":"2016","unstructured":"van Vught LA, Klein Klouwenberg PM, Spitoni C, et al.. Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis. JAMA. 2016, 315:1469-79. 10.1001\/jama.2016.2691","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12195","article-title":"Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe","volume":"19","author":"Goto M","year":"2013","unstructured":"Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013, 19:501-9. 10.1111\/1469-0691.12195","journal-title":"Clin Microbiol Infect"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-2294","article-title":"The impact of gram-negative bacilli in bacteremic skin and soft tissue infections among patients with diabetes","volume":"42","author":"Benavent E","year":"2019","unstructured":"Benavent E, Murillo O, Grau I, et al.. The impact of gram-negative bacilli in bacteremic skin and soft tissue infections among patients with diabetes. Diabetes Care. 2019, 42:e110-2. 10.2337\/dc18-2294","journal-title":"Diabetes Care"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.05.026","article-title":"Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment","volume":"96","author":"Peerapornratana S","year":"2019","unstructured":"Peerapornratana S, Manrique-Caballero CL, G\u00f3mez H, Kellum JA. Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int. 2019, 96:1083-99. 10.1016\/j.kint.2019.05.026","journal-title":"Kidney Int"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.21907","article-title":"Acute respiratory distress syndrome: advances in diagnosis and treatment","volume":"319","author":"Fan E","year":"2018","unstructured":"Fan E, Brodie D, Slutsky AS. Acute respiratory distress syndrome: advances in diagnosis and treatment. JAMA. 2018, 319:698-710. 10.1001\/jama.2017.21907","journal-title":"JAMA"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer M","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al.. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016, 315:801-10. 10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2019.07.002","article-title":"Antibiotic resistance in Pseudomonas aeruginosa - mechanisms, epidemiology and evolution","volume":"44","author":"Botelho J","year":"2019","unstructured":"Botelho J, Grosso F, Peixe L. Antibiotic resistance in Pseudomonas aeruginosa - mechanisms, epidemiology and evolution. Drug Resist Updat. 2019, 44:100640. 10.1016\/j.drup.2019.07.002","journal-title":"Drug Resist Updat"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/1476-0711-12-22","article-title":"New antibiotics for bad bugs: where are we?","volume":"12","author":"Bassetti M","year":"2013","unstructured":"Bassetti M, Merelli M, Temperoni C, Astilean A. New antibiotics for bad bugs: where are we?. Ann Clin Microbiol Antimicrob. 2013, 12:22. 10.1186\/1476-0711-12-22","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.2637","article-title":"Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012","volume":"311","author":"Kaukonen KM","year":"2014","unstructured":"Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA. 2014, 311:1308-16. 10.1001\/jama.2014.2637","journal-title":"JAMA"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/276161-clinical-and-microbiological-profile-of-gram-negative-infections-in-critically-ill-diabetic-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T16:21:26Z","timestamp":1722529286000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/276161-clinical-and-microbiological-profile-of-gram-negative-infections-in-critically-ill-diabetic-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.65955","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,1]]}}}